| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/16/2002 | US6372245 Plasticized bioerodible controlled delivery system |
| 04/16/2002 | US6372235 Compositions in solid form comprising an oil and a specific gelling compound, cosmetic treatment processes, and use of the compound |
| 04/16/2002 | US6372234 Containing an antibody |
| 04/16/2002 | US6372233 Lotions containing vitamin D3 derivatives |
| 04/16/2002 | US6372227 Oil in water emulsion containing a sterol and a saponin |
| 04/16/2002 | US6372222 Antigenic group B Streptococcus type II and type III polysaccharide fragments having a 2, 5-anhydro-D-mannose terminal structure and conjugate vaccine thereof |
| 04/16/2002 | US6372217 Methods for the treatment of CD7+ viral infection with TXU-7-PAP |
| 04/16/2002 | US6372209 Vaginal lactobacillus medicant |
| 04/16/2002 | US6372205 Pharmaceutical compositions containing antibody-enzyme conjugates in combination with prodrugs |
| 04/16/2002 | US6372204 Topical composition of unsaturated monoacid/monoacrylamide/polyfunctional monomer copolymer |
| 04/16/2002 | CA2266629C Taste-masked microcapsule compositions and methods of manufacture |
| 04/16/2002 | CA2186037C New pharmaceutical formulation and process |
| 04/11/2002 | WO2002029072A2 Targetting molecules for adenoviral vectors |
| 04/11/2002 | WO2002028929A1 Zwitterionic polymers |
| 04/11/2002 | WO2002028909A1 Starch |
| 04/11/2002 | WO2002028908A1 Pharmaceutically acceptable starch |
| 04/11/2002 | WO2002028895A2 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 04/11/2002 | WO2002028883A1 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 04/11/2002 | WO2002028882A1 Bile acid prodrugs of l-dopa and their use in the sustained treatment of parkinsonism |
| 04/11/2002 | WO2002028881A1 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration |
| 04/11/2002 | WO2002028836A1 Novel crystalline forms of a factor xa inhibitor |
| 04/11/2002 | WO2002028521A1 Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 04/11/2002 | WO2002028438A1 Lipopeptides as absorption enhancers for bioactive compounds |
| 04/11/2002 | WO2002028437A1 Regioselective liquid phase pegylation |
| 04/11/2002 | WO2002028436A1 Absorption enhancers |
| 04/11/2002 | WO2002028435A1 Pharmaceutical vehicle |
| 04/11/2002 | WO2002028426A1 Split enveloped virus preparation |
| 04/11/2002 | WO2002028411A1 Compounds for sustained release of orally delivered drugs |
| 04/11/2002 | WO2002028408A2 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 04/11/2002 | WO2002028402A1 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 04/11/2002 | WO2002028382A1 Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals |
| 04/11/2002 | WO2002028377A1 Ihnalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | WO2002028376A2 Chrono delivery formulations and method of use thereof |
| 04/11/2002 | WO2002028375A1 A controlled-release, parenterally administrable microparticle preparation |
| 04/11/2002 | WO2002028374A1 Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same |
| 04/11/2002 | WO2002028371A1 Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight |
| 04/11/2002 | WO2002028370A1 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 04/11/2002 | WO2002028362A2 Vaccine composition and stabilisation method |
| 04/11/2002 | WO2002028181A1 Sustained release pharmaceutical compositions containing metformin and method of its production |
| 04/11/2002 | WO2002009649A3 Cell internalized peptide-drug conjugates |
| 04/11/2002 | WO2001098328A3 Glycopeptide phosphonate derivatives |
| 04/11/2002 | WO2001097854A3 Method for the selective survival or selective growth of a target cell by the use of a conjugate, its use in therapeutics and/or diagnostics |
| 04/11/2002 | WO2001089559A3 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine |
| 04/11/2002 | WO2001087342A3 Delivery devices for treatment of vascular disease |
| 04/11/2002 | WO2001085200A3 Recombinant human cln2 protein and methods of its production and use |
| 04/11/2002 | WO2001085128A3 Skin protectant spray compositions |
| 04/11/2002 | WO2001082868A3 A medicinal aerosol formulation |
| 04/11/2002 | WO2001080920A3 Antimicrobial bioabsorbable materials |
| 04/11/2002 | WO2001080865A3 Joint repair using mesenchymal stem cells |
| 04/11/2002 | WO2001078680A3 Pharmaceutical compositions comprising fluvastatin |
| 04/11/2002 | WO2001072780A3 Polynucleotides for diagnosing mammary gland cancer |
| 04/11/2002 | WO2001066147A3 Antimicrobial compounds and formulations |
| 04/11/2002 | WO2001066085A3 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 04/11/2002 | WO2001058240A3 Photodynamic therapy for treating conditions of the eye |
| 04/11/2002 | WO2001054647A3 Pharmaceutical composition comprising carriers for products based on vitamin-e, papain and hyaluronidase |
| 04/11/2002 | WO2001034121A3 Multi-layer preparation in film form, consisting of hydrophilic polymers, for the rapid release of active ingredients |
| 04/11/2002 | WO2001028589A3 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase |
| 04/11/2002 | WO2001019405A3 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use |
| 04/11/2002 | US20020042466 Water-soluble or water-dispersible (co) polymers of hydroxyalkyl (meth) acrylates, a process for their preparation, and their use as coating agent, binder and/or film-forming excipient in pharmaceutical dosage forms |
| 04/11/2002 | US20020042448 Thickener-rheology modifier system for personal care compositions |
| 04/11/2002 | US20020042395 Method of treating high plasma cholesterol levels |
| 04/11/2002 | US20020042394 Antibiotic, images for diagnosis |
| 04/11/2002 | US20020042393 Excipient |
| 04/11/2002 | US20020042387 Administering nucleic acid as antiinflammatory agent |
| 04/11/2002 | US20020042378 Drug delivery; biocompatible polymer |
| 04/11/2002 | US20020042375 Method of treating cancer |
| 04/11/2002 | US20020042373 Administering thrombin receptor antagonist; bone disorders |
| 04/11/2002 | US20020042363 Nonantigenic stabilizer and physiologically active substance |
| 04/11/2002 | US20020042144 Preventing agglomeration of bodily fluid; obtain body fluid sample, incubate with enzyme inhibitors, monitor body fluid agglomeration |
| 04/11/2002 | US20020042128 Electroprocessed fibrin-based matrices and tissues |
| 04/11/2002 | US20020042127 Genetically engineered aggregation for use in the treatment of cancer |
| 04/11/2002 | US20020042086 Activating vascular system propagation; for use in the treatment of repefusion injury and bronci defects |
| 04/11/2002 | US20020041934 Contains separate nozzles for polymer and plasticizer dispersion without using organic solvent and without causing clogging |
| 04/11/2002 | US20020041898 Novel targeted delivery systems for bioactive agents |
| 04/11/2002 | US20020041893 Biodegradable polymer and drug complex; sustained release |
| 04/11/2002 | US20020041888 Suspension containing microspheres; apoptosis inducing compound |
| 04/11/2002 | US20020041884 Adenovirus formulations |
| 04/11/2002 | US20020041880 Mixture of angiogenesis inhibitor and prostate specific antigen |
| 04/11/2002 | US20020041865 Methods for treating tumors |
| 04/11/2002 | DE10049297A1 Wasserlösliche oder wasserdispergierbare (Co-)Polymerisate von Hydroxyalkyl(meth)acrylaten, Verfahren zu deren Herstellung sowie deren Verwendung als Überzugs-, Bindemittel und/oder filmbildender Hilfsstoff in pharmazeutischen Darreichungsformen Water-soluble or water-dispersible (co) polymers of hydroxyalkyl (meth) acrylates, processes for their preparation and their use as coating agent, binder and / or film-forming excipient in pharmaceutical presentations |
| 04/11/2002 | DE10048683A1 Zubereitung von Emulsionstyp W/O mit erhöhtem Wassergehalt auf der Basis niedrigviskoser,gut spreitender Lipidkomponenten,ferner enthaltend ein oder mehrere Alkylmethiconcopolyole und/oder Alkyl-Dimethicopolyole Preparation of Emulsion W / O type with increased water content based on low, well spreitender lipid components, further comprising one or more alkylmethicone copolyols and / or alkyl Dimethicopolyole |
| 04/11/2002 | DE10047278A1 Gelling and thickening agent useful in foods, animal feeds and pharmaceutical and cosmetic products comprises Cassia tora galactomannan |
| 04/11/2002 | CA2641575A1 Stabilization of solid thyroid drug formulations |
| 04/11/2002 | CA2641570A1 Stabilization of solid thyroid drug formulations |
| 04/11/2002 | CA2425906A1 Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 04/11/2002 | CA2424981A1 Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same |
| 04/11/2002 | CA2424936A1 Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight |
| 04/11/2002 | CA2424931A1 Starch |
| 04/11/2002 | CA2424896A1 A controlled-release, parenterally administrable microparticle preparation |
| 04/11/2002 | CA2424892A1 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 04/11/2002 | CA2424888A1 Pharmaceutically acceptable starch |
| 04/11/2002 | CA2424863A1 Vaccine composition and stabilisation method |
| 04/11/2002 | CA2424730A1 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 04/11/2002 | CA2424668A1 Targeting molecules for adenoviral vectors |
| 04/11/2002 | CA2424620A1 Inhalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | CA2424607A1 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 04/11/2002 | CA2424506A1 Cyclopeptides, a method for their preparation and their use as inhibitors or activators of angiogenesis |
| 04/11/2002 | CA2423610A1 Split enveloped virus preparation |
| 04/11/2002 | CA2422707A1 Regioselective liquid phase pegylation |
| 04/10/2002 | EP1195394A1 (Co-)Polymers of hydroxyalkyl(meth)acrylates, process for their preparation and their use in pharmaceutical dosage forms |